CBTX (NASDAQ:CBTX) reported quarterly earnings of $0.48 per share which beat the analyst consensus estimate of $0.42 by 14.29 percent. This is unchanged from the same period last year.
Avalon GloboCare Announces Execution Of Purchase Agreement For Acquisition Of SenlangBio In All Stock Transaction; Will Sell 15.6% Equity Interest In SenlangBio To Institutional Healthcare Investor For $30M
Avalon GloboCare Corp. (NASDAQ:AVCO) ("Avalon" or "the Company"), a clinical-stage global developer of cell-based technologies and therapeutics, today announced that it has entered into a
